1 Magnificent S&P 500 Dividend Stock Down 12% to Buy After Its Recent Pullback
The Motley Fool
NOVEMBER 11, 2024
Since spinning off from pharmaceutical juggernaut Pfizer in 2012, the company has grown its shareholders' initial investment by some sixfold, equating to an annualized total return of 17% over 12 years.
Let's personalize your content